Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 4, Pages 763-773
Publisher
Wiley
Online
2016-10-17
DOI
10.1002/art.39943
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Nerve Growth Factor (NGF) for Pain Management: What Does the Future Hold for NGF Antagonists?
- (2014) Bernard Bannwarth et al. DRUGS
- The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases
- (2014) Peter J. Hotez et al. PLoS Neglected Tropical Diseases
- Guidance on the management of pain in older people
- (2013) AGE AND AGEING
- The Sensitivity and Specificity of Subjective Memory Complaints and the Subjective Memory Rating Scale, Deterioration Cognitive Observee, Mini-Mental State Examination, Six-Item Screener and Clock Drawing Test in Dementia Screening
- (2013) S. Ramlall et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Adjudication process for joint events of interest in fulranumab clinical trial program
- (2013) R. Moskowitz et al. OSTEOARTHRITIS AND CARTILAGE
- The epidemiology and impact of pain in osteoarthritis
- (2013) T. Neogi OSTEOARTHRITIS AND CARTILAGE
- Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain
- (2013) Panna Sanga et al. PAIN
- Clinical management of patients with hip and knee osteoarthritis: patient satisfaction with treatment switch
- (2013) Sergio Gimenez et al. RHEUMATOLOGY INTERNATIONAL
- How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative
- (2013) Sarah R Kingsbury et al. ARTHRITIS RESEARCH & THERAPY
- Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?
- (2013) Igor Kissin Journal of Pain Research
- Opioids in chronic non-cancer pain
- (2011) Bob Kwok Bun Chan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain
- (2011) T.J. Schnitzer et al. OSTEOARTHRITIS AND CARTILAGE
- The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums
- (2010) Ellen M. Lavoie Smith et al. CANCER NURSING
- Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee
- (2010) Marc Afilalo et al. CLINICAL DRUG INVESTIGATION
- Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
- (2010) Nancy E. Lane et al. NEW ENGLAND JOURNAL OF MEDICINE
- OARSI recommendations for the management of hip and knee osteoarthritis
- (2010) W. Zhang et al. OSTEOARTHRITIS AND CARTILAGE
- Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicenter, randomized, placebo-controlled trial
- (2009) Pascal Richette et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More